Mustang Bio

Mustang Bio is a clinical-stage biotechnology company developing cell and gene therapies, with its current pipeline focused primarily on CAR-T programs and related treatments for difficult-to-treat cancers. The company has no approved commercial products and has not generated revenue from its development-stage candidates.

Relationship details are part of the Pro plan.